Allogeneic hemopoietic stem cell transplantation (BMT) after IV busulfan, and cyclophosphamide (BuCy) for acute myeloid leukemia (AML) and myelodysplasia (MDS).

被引：0
|
作者：
Andersson, BS
Cagnoni, P
Jones, R
Gian, V
Wingard, JR
Tarantolo, S
Kashyap, A
Forman, SJ
Hu, WH
Blume, KG
Fernandez, HF
Champlin, RE
机构：
[1] Univ Colorado, Boulder, CO 80309 USA
[2] Univ Florida, Gainesville, FL 32611 USA
[3] Univ Nebraska, Lincoln, NE 68583 USA
[4] Univ Miami, Coral Gables, FL 33124 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
729
引用
收藏
页码：167A / 167A
页数：1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation in acute myeloid leukemia
    Ali, Natasha
    Adil, Salman Naseem
    Shaikh, Mohammad Usman
    Masood, Nehal
    HEMATOLOGY REPORTS, 2012, 4 (04) : 95 - 97
  • [32] Allogeneic stem cell transplantation for acute myeloid leukemia
    Peccatori, Jacopo
    Ciceri, Fabio
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06): : 857 - 859
  • [33] Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
    Zander, A. R.
    Bacher, U.
    Finke, J.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2008, 105 (39): : 663 - U16
  • [34] Cumulative busulfan exposure is associated with relapse following busulfan and cyclophosphamide myeloablative allogeneic stem cell transplantation for acute myeloid leukaemia
    Wong, E.
    Kliman, D.
    Chau, M.
    Szer, J.
    Nath, C.
    Shaw, P.
    Ritchie, D.
    Gottlieb, D.
    Bajel, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S325 - S326
  • [35] Relationship between conditioning intensity and comorbidity in patients (Pts) with acute myeloid leukemia (AML) or myelodysplasia (MDS) receiving allogeneic hematopoietic cell transplantation (HCT).
    Sorror, M
    Storer, B
    Sandmaier, BM
    Maris, M
    Baron, F
    Maloney, D
    Scott, B
    Deeg, HJ
    Storb, R
    BLOOD, 2005, 106 (11) : 208A - 208A
  • [36] Busulfan Does Intensity and Outcomes in Reduced Intensity Allogeneic Stem Cell Transplantation for MDS/AML
    Chen, Yi-Bin
    Coughlin, Erin
    Cutler, Corey
    Kennedy, Kevin
    Alyea, Edwin P., III
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S114 - S115
  • [37] Allogeneic stem cell transplantation for advanced myeloid leukaemia and MDS following a synergistic combination of clofarabine ± fudarabine and IV busulfan
    Andersson, B. S.
    Valdez, B.
    Thall, P. F.
    Worth, L. L.
    Popat, U.
    Jones, R. B.
    Shpall, E. J.
    Hosing, C.
    Madden, T.
    McAdams, P.
    Alousi, A.
    Kebriaei, P.
    Champlin, R.
    de Lima, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S86 - S86
  • [38] Acute myeloid leukemia of donor cell origin after allogeneic stem cell transplantation in a patient with acute myeloid leukemia
    Hindilerden, F.
    Kantarcioglu, B.
    Guvenc, S.
    Goksoy, H. S.
    Buyukdogan, M.
    Ozcelik, T.
    Kucukkaya, R. Diz
    Arat, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5610 - 5610
  • [39] Comparison of allogeneic bone marrow transplantation (BMT) with cyclophosphamide - Total body irradiation (CyTBI) versus busulfan-cyclophosphamide (BuCy) conditioning regimens for acute myelogenous leukemia (AML) in first remission (CR1).
    Litzow, MR
    Bolwell, BJ
    Camitta, BM
    Copelan, EA
    Gale, RP
    Giralt, SA
    Keating, A
    Klein, JP
    Lazarus, HM
    Marks, DJ
    McCarthy, PL
    Miller, CB
    Milone, GA
    Perez, WS
    Prentice, HG
    Russell, JA
    Schultz, KR
    Trigg, ME
    Weisdorf, DJ
    Horowitz, MM
    BLOOD, 2000, 96 (11) : 480A - 480A
  • [40] Allogeneic transplantation in advanced hematologic malignancies after IV busulfan cyclofosfamide (BuCy)
    Andersson, BS
    Hai, T
    Madden, T
    Cagnoni, P
    Jones, R
    Bruton, J
    Martinka, S
    Holbert, K
    Giralt, S
    Przepiorka, D
    Lennon, S
    Spilker, B
    Gian, V
    Wingard, J
    Tarantolo, S
    Kashyap, A
    Forman, S
    Champlin, RE
    BLOOD, 1997, 90 (10) : 1003 - 1003
12345